Krishnamurthy and Co advises healthcare providers, pharma and biotech companies, and a wide range of private equity investors on transactions, intellectual property issues, and regulatory matters, with a particular strength in private equity and VC investments and joint ventures. The firm also has notable expertise in cross-border considerations and issues relating to patents- both application and protection, including contentious cases. The team is led by Naina Krishna Murthy in Mumbai, an experienced corporate practitioner who regularly advises PE and VC clients, alongside Bengaluru-based firm managing partner Shwetambari Rao, who is also strong on corporate and commercial life sciences and pharma matters, and Mumbai's Rukmini Roychowdhury.
Key clients
- Biocon Biologics Limited
- Lightrock India Holdings Limited
- JSW Ventures
- Majority Committee of Creditors of Unimark Remedies Limited
- VRMDB Services Pvt Ltd (Medibank)
- Nova Pulse IVF Clinic Private Limited
- Reliance Industries Limited
- Serosoft Solutions Private Limited
- Healthium MedTech Limited
Work highlights
- Advised Biocon Biologics in its acquisition of the global biosimilars business of Nasdaq-listed Viatris in a USD 3.33 billion deal.
- Advised Lightrock India Holdings Limited on its investment along with others through subscription to Series F Preference Shares of Phasorz Technologies Private Limited/Medibuddy in a USD 125 million deal.
- Advised JSW Ventures on its investment as lead investor in the Series A round of funding in Cure and Care Wellness Private Limited/CureSkin.
Practice head
The lawyer(s) leading their teams.
Naina Krishna Murthy, Shwetambari Rao, Rukmini Roychowdhury